|
市場調査レポート
商品コード
1463689
アジア太平洋地域の内皮機能不全：2028年までの市場予測 - 地域分析 - 原因別、検査タイプ別、エンドユーザー別Asia Pacific Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause, Test Type, and End User |
||||||
|
|
|||||||
|
|||||||
| アジア太平洋地域の内皮機能不全：2028年までの市場予測 - 地域分析 - 原因別、検査タイプ別、エンドユーザー別 |
|
出版日: 2024年02月07日
発行: The Insight Partners
ページ情報: 英文 128 Pages
納期: 即納可能
|
全表示
- 概要
- 図表
- 目次
アジア太平洋地域の内皮機能不全市場は、2022年の3億448万米ドルから2028年には4億551万米ドルに成長すると予測されています。2022年から2028年までのCAGRは4.9%と推定されます。
新規バイオマーカーの使用増加と治療戦略がアジア太平洋地域の内皮機能不全市場を後押し
内皮機能を調べることで、リスク層別化を改善し、疾患の早期発見を向上させ、治療介入に対する血管反応を評価することができます。内皮機能不全とアテローム性動脈硬化症の進行の根底にある病態生理学的メカニズムをより良い方法で理解し、内皮機能不全とアテローム性動脈硬化症を予防して冠動脈疾患（CAD）と関連合併症の発症リスクを低減するための新しいバイオマーカーと治療戦略を特定する研究が行われています。リキッドバイオプシーと新しい分子生物学的手法の使用により、内皮機能不全の分子・細胞マーカーが次々と同定され、動脈硬化の分子基盤に関する洞察が得られるとともに、動脈硬化やCADの予防・治療のための潜在的なバイオマーカーや治療標的が明らかになってきました。
バイオマーカーの調査とその臨床応用は過去数十年の間に飛躍的に増加しました。動脈硬化の病態生理に関する貴重な知見と新規治療法の開発は全身性バイオマーカーによってもたらされています。内皮機能不全と炎症はCADの発症と進行に中心的な役割を果たしています。炎症性メディエーターは、アテローム性動脈硬化プラーク内の炎症細胞や血管細胞、あるいは肝臓や脂肪組織などの臓器から分泌されます。
アジア太平洋地域の内皮機能不全市場概要
アジア太平洋地域の内皮機能不全市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。同地域の市場成長は、CVD、高血圧、糖尿病、慢性疾患の罹患率の上昇に伴う内皮機能不全の症例の増加と、高齢化人口の増加に起因しています。加えて、各国政府による診断技術への投資が増加し、診断方法が進歩したことも市場を牽引しています。
アジア太平洋地域の内皮機能不全市場の収益と2028年までの予測（金額）
アジア太平洋地域の内皮機能不全市場のセグメンテーション
アジア太平洋地域の内皮機能不全市場は、原因、検査タイプ、エンドユーザー、国別に細分化されます。
原因別に見ると、アジア太平洋地域の内皮機能不全市場は、高血圧、高コレステロール血症、肥満、糖尿病、ベーチェット病、その他に区分されます。高血圧セグメントは、2022年にアジア太平洋地域の内皮機能不全市場で最大のシェアを記録しました。
検査タイプに基づき、アジア太平洋地域の内皮機能不全市場は侵襲的検査と非侵襲的検査に区分されます。侵襲的検査セグメントが2022年のアジア太平洋地域の内皮機能不全市場シェアでより大きな割合を占めています。非侵襲的検査セグメントはさらに、フロー媒介拡張、末梢動脈トノメトリー（PAT）、静脈閉塞プレチスモグラフィー、循環マーカー、その他に細分化されます。
エンドユーザー別に見ると、アジア太平洋地域の内皮機能不全市場は病院、診断センター、クリニック、その他に分類されます。2022年のアジア太平洋地域の内皮機能不全市場シェアは病院セグメントが最大でした。
国別に見ると、アジア太平洋地域の内皮機能不全市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋地域の内皮機能不全市場は中国が独占。
ZOLL Medical Corp、Sphingo Tec GmbH、Perimed AB、Medizinische Messtechnik GmbHは、同地域の内皮機能不全市場で事業を展開する大手企業の一部です。
目次
目次
第1章 イントロダクション
第2章 アジア太平洋地域の内皮機能不全市場：要点
第3章 調査手法
- 調査範囲
- 2次調査
- 1次調査
第4章 アジア太平洋地域の内皮機能不全市場：市場情勢
- 概観
- PEST分析
- アジア太平洋地域のPEST分析
- 専門家の見解
第5章 アジア太平洋地域の内皮機能不全市場：主要市場力学
- 市場促進要因
- 心血管疾患の増加
- 高コレステロール、糖尿病、肥満の増加
- 市場抑制要因
- 内皮機能不全のスクリーニング技術に伴う欠点
- 市場機会
- 新規バイオマーカーと治療戦略の利用増加
- 今後の動向
- 内皮機能不全を評価するための非侵襲的方法の使用
- 影響分析
第6章 内皮機能不全市場：アジア太平洋地域分析
- アジア太平洋地域の内皮機能不全市場の収益と予測分析
第7章 アジア太平洋地域の内皮機能不全市場分析：原因別
- アジア太平洋地域の内皮機能不全市場：原因別、2022年・2028年（%）
- 高血圧
- 糖尿病
- 高コレステロール血症
- ベーチェット病
- 肥満症
- その他
第8章 アジア太平洋地域の内皮機能不全市場分析：検査タイプ別
- アジア太平洋地域の内皮機能不全市場：検査タイプ別、2022年・2028年（%）
- 侵襲的検査
- 非侵襲的検査
第9章 アジア太平洋地域の内皮機能不全市場分析：エンドユーザー別
- アジア太平洋地域の内皮機能不全市場：エンドユーザー別、2022年・2028年（%）
- 病院
- 診断センター
- 診療所
- その他
第10章 アジア太平洋地域の内皮機能不全市場-2028年までの収益と予測：国別分析
- アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他アジア太平洋地域
第11章 アジア太平洋地域の内皮機能不全市場：業界情勢
- 内皮機能不全市場における成長戦略
- 無機的成長戦略
- 有機的成長戦略
第12章 企業プロファイル
- ZOLL Medical Corp
- Sphingo Tec GmbH
- Perimed AB
- Medizinische Messtechnik GmbH
第13章 付録
List Of Tables
- Table 1. Techniques Used in to Assess Endothelial Function
- Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
- Table 3. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
- Table 4. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- Table 5. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
- Table 6. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 7. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
- Table 8. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- Table 9. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
- Table 10. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 11. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
- Table 12. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- Table 13. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
- Table 14. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 15. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
- Table 16. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- Table 17. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
- Table 18. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 19. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
- Table 20. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- Table 21. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
- Table 22. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 23. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
- Table 24. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
- Table 25. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
- Table 26. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
- Table 27. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
- Table 28. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
- Table 29. Glossary of Terms, Endothelial dysfunction market
List Of Figures
- Figure 1. Asia Pacific Endothelial Dysfunction Market Segmentation
- Figure 2. Asia Pacific Endothelial Dysfunction Market, by Country
- Figure 3. Asia Pacific Endothelial Dysfunction Market Overview
- Figure 4. Hypertension Account for Largest Share of Cause Segment in Asia Pacific Endothelial Dysfunction Market
- Figure 5. China Expected to Show Remarkable Growth During Forecast Period
- Figure 6. Asia Pacific: PEST Analysis
- Figure 7. Expert Opinion
- Figure 8. Asia Pacific Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
- Figure 9. Asia Pacific Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
- Figure 10. Asia Pacific Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
- Figure 11. Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Behcet's disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 15. Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 16. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Asia Pacific Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
- Figure 18. Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 24. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 25. Asia Pacific Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
- Figure 26. Hospitals and Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 27. Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 28. Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 29. Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- Figure 30. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
- Figure 31. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
- Figure 32. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 33. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 34. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 35. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 36. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 37. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
- Figure 38. Growth Strategies in the Endothelial Dysfunction Market
The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 to US$ 405.51 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2022 to 2028.
Rising Usage of Novel Biomarkers and Therapeutic Strategies Fuels Asia Pacific Endothelial Dysfunction Market
Examining endothelial function can improve risk stratification, improve early disease detection, and assess vascular response to therapeutic interventions. There are studies to understand the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis progression in a better way and identify new biomarkers and therapeutic strategies to prevent endothelial dysfunction and atherosclerosis to reduce the risk of developing coronary artery disease (CAD) and related complications. Using liquid biopsies and new molecular biology techniques has enabled the identification of a growing list of molecular and cellular markers of endothelial dysfunction that have provided insight into the molecular basis of atherosclerosis as well as potential biomarkers and therapeutic targets for the prevention and treatment of atherosclerosis and CAD.
Research on biomarkers and their clinical application has increased exponentially over the last few decades. Invaluable insight into the pathophysiology of atherosclerosis and the development of novel therapies have been provided by systemic biomarkers. Endothelial dysfunction and inflammation play a central role in the development and progression of CAD. Inflammatory mediators are secreted by inflammatory and vascular cells in atherosclerotic plaque or by organs such as the liver or adipose tissue.
Asia Pacific Endothelial Dysfunction Market Overview
The endothelial dysfunction market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market in the region is attributed to the increasing cases of endothelial dysfunction with the rising incidence of CVD, hypertension, diabetes, and chronic diseases, coupled with the growing aging population. In addition, the market is driven by increasing investments in diagnostics techniques by the respective country governments, resulting in advancements in diagnostics methods.
Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Endothelial Dysfunction Market Segmentation
The Asia Pacific endothelial dysfunction market is segmented into cause, test type, end user, and country.
Based on cause, the Asia Pacific endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, Behcet's disease, and others. The hypertension segment registered the largest Asia Pacific endothelial dysfunction market share in 2022.
Based on test type, the Asia Pacific endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Asia Pacific endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.
Based on end user, the Asia Pacific endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Asia Pacific endothelial dysfunction market share in 2022.
Based on country, the Asia Pacific endothelial dysfunction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endothelial dysfunction market in 2022.
ZOLL Medical Corp, Sphingo Tec GmbH, Perimed AB, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.
Table Of Contents
Table of Content
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Asia Pacific Endothelial Dysfunction Market - by Cause
- 1.3.2 Asia Pacific Endothelial Dysfunction Market - by Test Type
- 1.3.3 Asia Pacific Endothelial Dysfunction Market - by End User
- 1.3.4 Asia Pacific Endothelial Dysfunction Market - by Country
2. Asia Pacific Endothelial Dysfunction Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Asia Pacific Endothelial Dysfunction Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
- 4.3 Expert Opinion
5. Asia Pacific Endothelial Dysfunction Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Incidences of Cardiovascular Diseases
- 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
- 5.2 Market Restraints
- 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
- 5.3 Market Opportunities
- 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
- 5.4 Future Trends
- 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
- 5.5 Impact Analysis
6. Endothelial Dysfunction Market - Asia Pacific Analysis
- 6.1 Asia Pacific Endothelial Dysfunction Market Revenue Forecast and Analysis
7. Asia Pacific Endothelial Dysfunction Market Analysis - by Cause
- 7.1 Overview
- 7.2 Asia Pacific Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
- 7.3 Hypertension
- 7.3.1 Overview
- 7.3.2 Hypertension: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 7.4 Diabetes
- 7.4.1 Overview
- 7.4.2 Diabetes: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 7.5 Hypercholestrolaemia
- 7.5.1 Overview
- 7.5.2 Hypercholestrolaemia: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 7.6 Behcet's Disease
- 7.6.1 Overview
- 7.6.2 Behcet's Disease: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 7.7 Obesity
- 7.7.1 Overview
- 7.7.2 Obesity: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Endothelial Dysfunction Market Analysis - by Test Type
- 8.1 Overview
- 8.2 Asia Pacific Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
- 8.3 Invasive Tests
- 8.3.1 Overview
- 8.3.2 Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4 Non-Invasive Tests
- 8.4.1 Overview
- 8.4.2 Non-Invasive Tests: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Flow Mediated Dilatory
- 8.4.3.1 Overview
- 8.4.3.2 Flow Mediated Dilatory: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.4 Venous Occlusion Plethysmography
- 8.4.4.1 Overview
- 8.4.4.2 Venous Occlusion Plethysmography: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.5 Peripheral Arterial Tonometry (PAT)
- 8.4.5.1 Overview
- 8.4.5.2 Peripheral Arterial Tonometry (PAT): Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.6 Circulating Markers
- 8.4.6.1 Overview
- 8.4.6.2 Circulating Markers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.7 Others
- 8.4.7.1 Overview
- 8.4.7.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Endothelial Dysfunction Market Analysis - by End User
- 9.1 Overview
- 9.2 Asia Pacific Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 9.4 Diagnostics Centers
- 9.4.1 Overview
- 9.4.2 Diagnostics Centers: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 9.5 Clinics
- 9.5.1 Overview
- 9.5.2 Clinics: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis
- 10.1 Asia Pacific: Endothelial Dysfunction Market
- 10.1.1 Overview
- 10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.1.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
- 10.1.1.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.1.1.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
- 10.1.1.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.1.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
- 10.1.1.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.1.1.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
- 10.1.1.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.1.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
- 10.1.1.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.1.1.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
- 10.1.1.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Overview
- 10.1.1.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.1.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
- 10.1.1.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.1.1.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
- 10.1.1.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Overview
- 10.1.1.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.1.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
- 10.1.1.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.1.1.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
- 10.1.1.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Overview
- 10.1.1.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.1.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
- 10.1.1.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.1.1.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
- 10.1.1.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1 Overview
11. Asia Pacific Endothelial Dysfunction Market-Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Endothelial Dysfunction Market
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
- 11.4 Organic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 ZOLL Medical Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Sphingo Tec GmbH
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Perimed AB
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Medizinische Messtechnik GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
